IPP Bureau
OBESITAS 2026 concludes with focus on India’s rising obesity burden
By IPP Bureau - May 05, 2026
The conference brought together over 500 doctors and 150 nutritionists to discuss emerging obesity-related challenges
Govt, academia and industry collaboration crucial for scientific progress: Dr Jitendra Singh
By IPP Bureau - May 05, 2026
The Minister emphasised that scientific institutions must actively communicate their achievements and engage with stakeholders
Swiss Biotech Association reports CHF 7.5 billion revenue for Switzerland’s biotech Industry in 2025
By IPP Bureau - May 05, 2026
The private funding rose 38% amid growing international collaborations and CDMO demand
Novartis locks in $23 billion US expansion with seventh new facility
By IPP Bureau - May 05, 2026
The latest addition, a new API facility in Morrisville, North Carolina, will produce key components for solid dosage tablets, capsules, and RNA therapeutics
Dr Odin launches ‘Odin Buddy’ kids’ nebulizer for child-friendly respiratory care
By IPP Bureau - May 05, 2026
New pediatric nebulizer combines playful design and engaging features to make breathing treatments less stressful for children and parents
OneSource powers second generic semaglutide nod in Canada
By IPP Bureau - May 05, 2026
Approval marks the second generic semaglutide clearance in Canada and strengthens OneSource’s position in complex injectable CDMO programs
Medanta appoints Dr Shalini Tyagi as Director, Paediatric Care at Noida unit
By IPP Bureau - May 05, 2026
Appointment strengthens Medanta’s pediatric super-specialty and respiratory care services in the Delhi-NCR region.
KPMG report finds healthcare CEOs betting big on AI amid workforce and system pressures
By IPP Bureau - May 05, 2026
Report highlights growing confidence in digitalisation and AI, even as healthcare leaders remain concerned about workforce gaps, cybersecurity, and data readiness
Redcliffe Labs elevates Gaurav Jain as Chief Operating Officer
By IPP Bureau - May 05, 2026
Leadership transition strengthens Redcliffe Labs’ focus on scaling technology-led diagnostics, operational excellence, and preventive healthcare access
World Asthma Day: Apollo Spectra Hospital urges early diagnosis and treatment adherence
By IPP Bureau - May 05, 2026
Doctors highlight rising respiratory risks linked to pollution, seasonal changes, and poor treatment adherence amid increasing asthma burden in India
Lupin receives USFDA approval for generic Ravicti oral liquid
By IPP Bureau - May 05, 2026
Approval expands Lupin’s specialty portfolio in the US market for treatment of urea cycle disorders
Healthcare policymakers lay thrust on genetic screening and indigenous therapies for rare diseases
By IPP Bureau - May 05, 2026
Under the new policy, financial assistance has been increased to Rs 50 lakh per patient to improve treatment access
India and Japan deepen healthcare collaboration at 3rd joint committee meeting
By IPP Bureau - May 05, 2026
Discussions focused on digital health, non-communicable diseases, resilient supply chains, medical innovation, and healthcare workforce development
Zydus Lifesciences subsidiary faces Rs 9 million GST demand notice
By IPP Bureau - May 05, 2026
Company plans to appeal against CGST order related to alleged inadmissible input tax credit claims
NIFTY Pharma remains resilient amid mixed market sentiment
By IPP Bureau - May 05, 2026
Pharma and healthcare stocks stay in focus as investors track earnings, USFDA approvals, hospital growth, and global market pressures
